LOKON PHARMA is a Swedish biotech company in the forefront of developing immunostimulatory gene therapy for cancer-based on oncolytic viruses. Innovative gene engineering, solid expertise in cancer biology and immunology, as well as a genuine curiosity in life science expand Lokon’s pipeline towards groundbreaking new therapeutics for patients with high unmet medical need.
| Website | http://lokonpharma.com |
| Revenue | $1 million |
| Employees | 5 (4 on RocketReach) |
| Founded | 2011 |
| Address | 14 Bredgränd, Uppsala, Uppsala 753 20, SE |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Biotechnology, Pharmaceuticals, Manufacturing, Science and Engineering, Distributors/Wholesale, Therapeutics, Health Care |
| Keywords | Oncolytic Viruses, Gene Therapy, Cancer Immunotherapy, Immunotherapy, Oncology, Biotechnology, Cancer Biology, Cancer Treatment, Biotech, Viral Therapy, Viral Vectors, Immunology Research, Biopharmaceutical, Drug Development, Pharmaceutical Research, Pharmaceutical, Clinical Trials |
| Competitors | Biogen, Amgen, Roche, Novartis, Genentech, Pfizer, AstraZeneca, Bristol Myers Squibb, Lilly India, AbbVie +44 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Lokon Pharma AB employee's phone or email?
The Lokon Pharma AB annual revenue was $1 million in 2026.
4 people are employed at Lokon Pharma AB.
Lokon Pharma AB is based in Uppsala, Uppsala.
The NAICS codes for Lokon Pharma AB are [32, 325, 3254].
The SIC codes for Lokon Pharma AB are [28, 80, 283].